![Yi Hui Wu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Yi Hui Wu
Algemeen Directeur bij Hangzhou Puyang Investment Management Co., Ltd.
Vermogen: 72 M $ op 31-05-2024
Profiel
Yi Hui Wu currently works at Zhejiang Tiansong Medical Instrument Co., Ltd., as Independent Director from 2019, Hangzhou Puyang Investment Management Co., Ltd., as General Manager & Executive Director from 2016, and Medtide, Inc., as Non-Executive Director from 2024.
Mr. Wu also formerly worked at Zhejiang Jindao Technology Co., Ltd., as Director.
Mr. Wu received his graduate degree from Zhejiang University of Finance & Economics.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
30-09-2023 | 10 363 914 ( 1.94% ) | 61 M $ | 31-05-2024 | |
31-12-2023 | 3 654 327 ( 4.04% ) | 11 M $ | 31-05-2024 |
Actieve functies van Yi Hui Wu
Bedrijven | Functie | Begin |
---|---|---|
Hangzhou Puyang Investment Management Co., Ltd.
![]() Hangzhou Puyang Investment Management Co., Ltd. Investment ManagersFinance Hangzhou Puyang Investment Management Co., Ltd. provides investment management services. The company was founded on April 15, 2009 and is headquartered in Hangzhou, China. | Algemeen Directeur | 13-10-2016 |
Zhejiang Tiansong Medical Instrument Co., Ltd.
![]() Zhejiang Tiansong Medical Instrument Co., Ltd. Medical SpecialtiesHealth Technology Zhejiang Tiansong Medical Instrument Co., Ltd. engages in the research and development, production, and sale of endoscopic minimally invasive medical devices. Its products include abdominal surgery, orthopedic surgery, microsurgery, and gynecological endoscope minimally invasive medical equipment. The company was founded by Tian Song Xu and Tang Zhu Xu on August 28, 1998 and is headquartered in Hangzhou, China. | Directeur/Bestuurslid | 16-09-2019 |
Taide Pharmaceutical (Zhejiang) Co., Ltd.
![]() Taide Pharmaceutical (Zhejiang) Co., Ltd. BiotechnologyHealth Technology Medtide, Inc. is a peptide focused contract research, development and manufacturing organization. It services include contract research organization services, namely peptide new chemical entity discovery synthesis, contract development and manufacturing organization services, namely peptide chemistry, manufacturing and controls development, and contract manufacturing organization services, namely peptide NCE and generic drug commercial manufacturing. The company was founded by Li Xiang and Xu Qi on June 11, 2020 and is headquartered in Shaoxing, China. | Directeur/Bestuurslid | 01-01-2022 |
Eerdere bekende functies van Yi Hui Wu
Bedrijven | Functie | Einde |
---|---|---|
ZHEJIANG JINDAO TECHNOLOGY CO., LTD. | Directeur/Bestuurslid | - |
Opleiding van Yi Hui Wu
Zhejiang University of Finance & Economics | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
![]() | Health Technology |
ZHEJIANG JINDAO TECHNOLOGY CO., LTD. | Distribution Services |
Bedrijven in privébezit | 2 |
---|---|
Hangzhou Puyang Investment Management Co., Ltd.
![]() Hangzhou Puyang Investment Management Co., Ltd. Investment ManagersFinance Hangzhou Puyang Investment Management Co., Ltd. provides investment management services. The company was founded on April 15, 2009 and is headquartered in Hangzhou, China. | Finance |
Taide Pharmaceutical (Zhejiang) Co., Ltd.
![]() Taide Pharmaceutical (Zhejiang) Co., Ltd. BiotechnologyHealth Technology Medtide, Inc. is a peptide focused contract research, development and manufacturing organization. It services include contract research organization services, namely peptide new chemical entity discovery synthesis, contract development and manufacturing organization services, namely peptide chemistry, manufacturing and controls development, and contract manufacturing organization services, namely peptide NCE and generic drug commercial manufacturing. The company was founded by Li Xiang and Xu Qi on June 11, 2020 and is headquartered in Shaoxing, China. | Health Technology |